Ulrike Köhl

9PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2026
Real-World Data from a Single-Center, Large Academic Centralized Manufacturing of CD19 CAR T Cells in an Industry Partnership.

|Aug 03, 2026
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.

|Jan 26, 2026
Anti-CD4 antibody-modulated transplants for GVHD prevention in hematopoietic cell transplantation.

Kristina Roth, Dennis Loeffler, Conny Blumert

|Sep 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities.

Karl Petri, Elvira D'Ippolito, Annette Künkele

|Dec 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.

Miriam Alb, Kristin Reiche, Michael Rade

|Oct 23, 2024
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

David Fandrei, Sabine Seiffert, Michael Rade

Pageof 2

Frequent Collaborators

4 joint publications

Kristin Reiche

2 joint publications

Maik Friedrich

2 joint publications

Maximilian Merz

2 joint publications

Vladan Vucinic